Cambridge Healthtech Institute’s Third Annual

Digital Pathology

Transforming Medicine in a Digital World

February 16-18, 2015 | Moscone North Convention Center | San Francisco, CA
Part of the 22nd Annual Molecular Medicine Tri-Conference

 

The field of pathology is being reshaped by advances in digital imaging techniques, systems for analyzing data and the increased demand for access. This conference will look at the present and future of digital pathology from many different aspects, including market projections and trends, to technical progress in imaging techniques, and approaches to mining and storage of big data. For digital imaging and molecular technologies to be utilized in routine practice, many factors influencing adoption should be evaluated, including regulation, standards, and validation of imaging methods. Learn how digital pathology is creating advanced diagnoses for the future.

Scientific Advisory Board

Kenneth J. Bloom, M.D., Chief Medical Officer, Clarient, Inc.

Eric F. Glassy, M.D., Medical Director, Pathology, Inc.

Liron Pantanowitz, M.D., Associate Professor, Pathology, University of Pittsburgh Medical Center

David L. Rimm, M.D., Ph.D., Professor, Pathology, Yale University


DIGITAL PATHOLOGY PREDICTIONS: MARKET ANALYSIS & TRENDS

Mobile Industry: Exploiting Smartphones for Digital Pathology

Douglas J. Hartman, M.D., Assistant Professor, Pathology, University of Pittsburgh Medical Center

DPA – Past, Present & Future

Kim Dickinson, M.D., MBA, MPH, Senior Medical Director, Lab Corp Clinical Trials; President, Digital Pathology Association


IN VIVO MICROSCOPY

In vivo GI Pathology

Gregory Y. Lauwers, M.D., Vice Chairman, Pathology; Chief, Gastrointestinal Pathology Service, Massachusetts General Hospital; Professor; Pathology, Harvard Medical School

Talk Title to be Announced

Jeffrey Fine, M.D., Assistant Professor, Pathology, University of Pittsburgh

26 Easy Steps to Implementing an in vivo Microscopy Service in Pathology

Andrew Quinn, M.D., Fellow, Cytology, Pathology, Brigham and Women’s Hospital

Collaboration across Multi Disciplinary Teams

Chrystal Adams, Associate Vice President, Marketing, XIFIN


LARGE-SCALE DEPLOYMENT OF DIGITAL PATHOLOGY

Large-Scale Deployment of Digital Pathology – The Importance of Color

Elizabeth A. Krupinski, Ph.D., Professor, Medical Imaging, University of Arizona

How Digital Pathology Enables New Business and Clinical Models in Pathology

Robert Michel, Editor-In-Chief, The Dark Report

Digital Pathology & Patent Law: Lessons Learned & Advice for Entrepreneurs

Sury Vepa, Ph.D., J.D., Senior Licensing and Patenting Manager, Office of Intramural Research; Office of Technology Transfer, NIH

Digital Pathology: Regulatory Barriers to Adoption

Eric F. Glassy, M.D., FCAP, Medical Director, Pathology, Affiliated Pathologist Group


QUANTITATIVE DETECTION OF BIOMARKERS FOR NEXT-GENERATION IMMUNOHISTOCHEMISTRY

Next-Generation Immunohistochemistry Using Multiplexed Ion Beam Imaging

Michael Angelo, M.D., Ph.D., Instructor, Pathology, Stanford University

User Perspective of the Perkin Elmer Vectra System For Multiplexed Fluorescence for Multiplexed Assessment of Immunoscore

Michael D. Feldman, M.D., Ph.D., Associate Professor, Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania

Domain-Specific Antibodies as Biomarkers

David L. Rimm, M.D., Ph.D., Professor, Pathology, Yale University School of Medicine


SPECIALIZED ADOPTION OF DIGITAL PATHOLOGY

Remote Eye Tracking to Assess Pathologist Interaction with Digital Whole-Slide Images

Beverly E. Faulkner-Jones, M.D. Ph.D., Staff Pathologist, Pathology, Beth Israel Deaconess Medical Center

High Resolution Histology 3D Reconstruction and Analysis

Yukako Yagi, Ph.D., Director, MGH Pathology Imaging & Communication Technology (PICT) Center, Massachusetts General Hospital; Affiliated Faculty, Wellman Center for Photomedicine, Massachusetts General Hospital; Assistant Professor, Pathology, Harvard Medical School

Google Glass for Pathology

Liron Pantanowitz, M.D., Associate Professor, Pathology, University of Pittsburgh Medical Center


BIG DATA AND THE CLOUD

Whole-Slide Imaging Data Storage: A “Dickens” of a Tale: Please Sir, Can I Have Another Petabyte?

Michael W. Riben, M.D., Medical Director, Laboratory Informatics; Associate Professor, Pathology, MD Anderson Cancer Center


WSI, BIOIMAGING & BIOINFORMATICS RESEARCH

Hot Spot Detection for Histopathological Images

Metin N. Gurcan, Ph.D., Associate Professor, Biomedical Informatics, The Ohio State University

WSI & Molecular Decision Support Systems

Mark Boguski, M.D., Ph.D., Founder & CMO, Genome Health Solutions


NEXT STEPS FOR INTEGRATION: Moving Digital Pathology into Real Practice

CAP: Using Digital Imaging to Select Cells for NGS

Kenneth J. Bloom, M.D., Chief Medical Officer, Clarient, Inc.

Clinical Performance and Regulatory Considerations for in vitro Diagnostic Use of Whole-Slide Imaging in the U.S.

Michael C. Montalto, Ph.D., Senior Vice President, Clinical, Medical & Scientific Affairs, GE Healthcare



For more details on the conference, please contact:
Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: 781-972-5464
E: clingham@healthtech.com 

For partnering and sponsorship information, please contact:
Jon Stroup
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

Joseph Vacca
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com 

 

 

  2015 Plenary Sessions 

2015 MMTC Prelim Agenda 

Premier Sponsors:

Elsevier 


Jackson Laboratory - small logo 

Leica Biosystems 
 

 NanoString2   

 

Singulex 

Thomson Reuters-Large 


Local Partners:

BayBio 


biocube 


Cabs 

City of SSF